HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells
Standard
HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells. / Fittje, Pia; Hölzemer, Angelique; Garcia-Beltran, Wilfredo F; Vollmers, Sarah; Niehrs, Annika; Hagemann, Kerri; Martrus, Glòria; Körner, Christian; Kirchhoff, Frank; Sauter, Daniel; Altfeld, Marcus.
In: PLOS PATHOG, Vol. 18, No. 6, e1010572, 06.2022.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - HIV-1 Nef-mediated downregulation of CD155 results in viral restriction by KIR2DL5+ NK cells
AU - Fittje, Pia
AU - Hölzemer, Angelique
AU - Garcia-Beltran, Wilfredo F
AU - Vollmers, Sarah
AU - Niehrs, Annika
AU - Hagemann, Kerri
AU - Martrus, Glòria
AU - Körner, Christian
AU - Kirchhoff, Frank
AU - Sauter, Daniel
AU - Altfeld, Marcus
PY - 2022/6
Y1 - 2022/6
N2 - Antiviral NK cell activity is regulated through the interaction of activating and inhibitory NK cell receptors with their ligands on infected cells. HLA class I molecules serve as ligands for most killer cell immunoglobulin-like receptors (KIRs), but no HLA class I ligands for the inhibitory NK cell receptor KIR2DL5 have been identified to date. Using a NK cell receptor/ligand screening approach, we observed no strong binding of KIR2DL5 to HLA class I or class II molecules, but confirmed that KIR2DL5 binds to the poliovirus receptor (PVR, CD155). Functional studies using primary human NK cells revealed a significantly decreased degranulation of KIR2DL5+ NK cells in response to CD155-expressing target cells. We subsequently investigated the role of KIR2DL5/CD155 interactions in HIV-1 infection, and showed that multiple HIV-1 strains significantly decreased CD155 expression levels on HIV-1-infected primary human CD4+ T cells via a Nef-dependent mechanism. Co-culture of NK cells with HIV-1-infected CD4+ T cells revealed enhanced anti-viral activity of KIR2DL5+ NK cells against wild-type versus Nef-deficient viruses, indicating that HIV-1-mediated downregulation of CD155 renders infected cells more susceptible to recognition by KIR2DL5+ NK cells. These data show that CD155 suppresses the antiviral activity of KIR2DL5+ NK cells and is downmodulated by HIV-1 Nef protein as potential trade-off counteracting activating NK cell ligands, demonstrating the ability of NK cells to counteract immune escape mechanisms employed by HIV-1.
AB - Antiviral NK cell activity is regulated through the interaction of activating and inhibitory NK cell receptors with their ligands on infected cells. HLA class I molecules serve as ligands for most killer cell immunoglobulin-like receptors (KIRs), but no HLA class I ligands for the inhibitory NK cell receptor KIR2DL5 have been identified to date. Using a NK cell receptor/ligand screening approach, we observed no strong binding of KIR2DL5 to HLA class I or class II molecules, but confirmed that KIR2DL5 binds to the poliovirus receptor (PVR, CD155). Functional studies using primary human NK cells revealed a significantly decreased degranulation of KIR2DL5+ NK cells in response to CD155-expressing target cells. We subsequently investigated the role of KIR2DL5/CD155 interactions in HIV-1 infection, and showed that multiple HIV-1 strains significantly decreased CD155 expression levels on HIV-1-infected primary human CD4+ T cells via a Nef-dependent mechanism. Co-culture of NK cells with HIV-1-infected CD4+ T cells revealed enhanced anti-viral activity of KIR2DL5+ NK cells against wild-type versus Nef-deficient viruses, indicating that HIV-1-mediated downregulation of CD155 renders infected cells more susceptible to recognition by KIR2DL5+ NK cells. These data show that CD155 suppresses the antiviral activity of KIR2DL5+ NK cells and is downmodulated by HIV-1 Nef protein as potential trade-off counteracting activating NK cell ligands, demonstrating the ability of NK cells to counteract immune escape mechanisms employed by HIV-1.
KW - Antiviral Agents/metabolism
KW - Down-Regulation
KW - HIV Infections
KW - HIV Seropositivity
KW - HIV-1
KW - Humans
KW - Killer Cells, Natural
KW - Ligands
KW - Receptors, Natural Killer Cell/metabolism
KW - Receptors, Virus
KW - nef Gene Products, Human Immunodeficiency Virus/genetics
U2 - 10.1371/journal.ppat.1010572
DO - 10.1371/journal.ppat.1010572
M3 - SCORING: Journal article
C2 - 35749424
VL - 18
JO - PLOS PATHOG
JF - PLOS PATHOG
SN - 1553-7366
IS - 6
M1 - e1010572
ER -